The Disease Susceptibility Genetic Test-Esophageal Cancer
The Disease Susceptibility Genetic Test-Esophageal Cancer
This genetic testing for esophageal cancerbases on biochip precise healthcare solutions technology evaluates the risk of esophageal cancer from the perspective of genetics and provide guidance on disease prevention. Esophageal cancer genetic testing aims to identify genetic variants or mutations associated with an increased susceptibility to esophageal cancer. Genetic testing can help assess the likelihood of developing the disease and guide personalized risk management or screening strategies.
Applicable Population of the Disease Susceptibility Genetic Test-Esophageal Cancer
Is Esophageal Cancer Hereditary?
Esophageal cancer can have both environmental and genetic factors contributing to its development. While most cases of esophageal cancer are not inherited, there are certain genetic factors that can increase the risk of developing this type of cancer.
One of the most well-known genetic factors associated with esophageal cancer is a condition called familial esophageal cancer. It is a rare inherited condition in which multiple family members are affected by esophageal cancer. This condition has been associated with specific genetic mutations, such as mutations in genes like TP53 and CDH1. Individuals with familial esophageal cancer have a higher risk of developing the disease than the general population.
Apart from familial esophageal cancer, there are other genetic predispositions that can contribute to an increased risk of esophageal cancer. For example, certain genetic variants related to alcohol metabolism (such as ADH and ALDH genes) may impact the risk of developing esophageal cancer in individuals who consume alcohol excessively.
However, it's important to note that the majority of esophageal cancer cases occur sporadically, without a clear hereditary link. Environmental factors such as tobacco and alcohol use, obesity, gastroesophageal reflux disease (GERD), and exposure to certain chemicals and substances (like asbestos) play a significant role in the development of esophageal cancer.
If you have concerns about your risk for esophageal cancer or a family history of the disease, it's best to consult a healthcare professional or a genetic counselor who can provide personalized guidance based on your specific situation and family history.
Specification of the Disease Susceptibility Genetic Test-Esophageal Cancer
|
Sample types |
Venous blood / Oral swab |
|
TAT |
9 working days |
CapitalBio TechnologyCo, Ltd. is the industrialized platform of CapitalBio Corporation and Biochip Beijing National Engineering Research Center and one of the core enterprises of Tsinghua University in the field of life and health. CapitalBio Technology was registered and established in August 2012 and had production, R&D bases and marketing operation centers for biochips, instrument and equipment in Beijing, Shanghai, Chongqing, Chengdu, Dongguan, Hong Kong (China) and San Diego and other places, with a total office area of over 150,000 ㎡and employees of over 2,000 persons.
As one of genetic sequencing companies, we will do our best to meet all the needs of customers.
在线联系供应商
Other supplier products
 |
Neuromuscular Disorders | Neuromuscular Disorders List Neuromuscular disorders include a wide-range of diseases affecting the peripheral nervous system, which consists of a... |
 |
Forensic Platform | Forensic DNA identification is a scientific and technological weapon for investigation and litigation. The inspection includes DNA extraction, PCR ... |
 |
CNV-seq Detection (Semiconductor Sequencing) | CNV-seq Detection (Semiconductor Sequencing) The detection kit, which is based on the BES 4000 platform, is used to perform low-depth whole-genome... |
 |
CapitalBio® Microarray Hybridization Station | CapitalBio® Microarray Hybridization Station The CapitalBio® BioMixerTMII is a microarray hybridization station that uses continuous 3-D m... |
 |
CNV-seq Detection (Semiconductor Sequencing) | The detection kit, which is based on the BES 4000 platform, is used to perform low-depth whole-genome sequencing of DNA. The sequencing results are... |
Same products
 |
High Precision Filter Infusion Set Sterile Disposable Clinical IV Therapy | 卖方: Hebei Zongkai Technology Co., LTD | Products DescriptionSterile Luer Lock Infusion Giving Sets IV Set Medical Intravenous Disposable ... |
 |
High Precision Filter Infusion Set Sterile Disposable Clinical IV Therapy | 卖方: Hebei Zongkai Technology Co., LTD | Products DescriptionSterile Luer Lock Infusion Giving Sets IV Set Medical Intravenous Disposable ... |
 |
Class I Sterile Test Tube PET Plastic Body Fluid Collection Clinical Use | 卖方: Hebei Zongkai Technology Co., LTD | Description of Disposable syringe: 1) Disposable syringe with three parts,luer lock or luer slip... |
 |
Class I Sterile Test Tube PET Plastic Body Fluid Collection Clinical Use | 卖方: Hebei Zongkai Technology Co., LTD | Description of Disposable syringe: 1) Disposable syringe with three parts,luer lock or luer slip... |
 |
Class I Sterile Test Tube PET Plastic Body Fluid Collection Clinical Use | 卖方: Hebei Zongkai Technology Co., LTD | Description of Disposable syringe: 1) Disposable syringe with three parts,luer lock or luer slip... |
